Review: taking Orencia and Pamelor together


Summary

Drug interactions are reported among people who take Orencia and Pamelor together. This review analyzes the effectiveness and drug interactions between Orencia and Pamelor. It is created by eHealthMe based on reports of 24 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Orencia and Pamelor >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Orencia

Orencia has active ingredients of abatacept. It is often used in rheumatoid arthritis. (latest outcomes from Orencia 10,470 users)

Pamelor

Pamelor has active ingredients of nortriptyline hydrochloride. It is often used in depression. (latest outcomes from Pamelor 2,369 users)

On Aug, 25, 2016

24 people who take Orencia, Pamelor are studied.


Number of reports submitted per year:

Orencia and Pamelor drug interactions.

Drug effectiveness over time:

Orencia:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 100.0% - (1 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Pamelor:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Orencia:
  • female: 100.0% - (1 of 1 people)
  • male: 0.0% - (0 of 0 people)
Pamelor:
  • female: 100.0% - (1 of 1 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Orencia:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 0.0% - (0 of 0 people)
Pamelor:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • fatigue
  • migraine
not specified:
  • rash generalised
  • myelodysplastic syndrome
  • pneumonia
  • systemic lupus erythematosus
  • asthma
  • lower respiratory tract infection
  • fatigue
  • pyrexia
  • nausea
  • pruritus

Most common drug interactions by gender *:

female:
  • nausea
  • pruritus
  • pyrexia
  • rash generalised
  • anxiety
  • systemic lupus erythematosus
  • asthma
  • fatigue
  • lower respiratory tract infection
  • pneumonia
male:
  • myelodysplastic syndrome
  • thrombocytopenia
  • liver injury
  • pneumonia
  • renal failure acute

Most common drug interactions by age *:

30-39:
  • asthma
  • lower respiratory tract infection
  • pneumonia
  • fatigue
  • pyrexia
  • anxiety
  • cholecystitis chronic
  • emotional distress
  • gallbladder disorder
  • general physical health deterioration
40-49:
  • systemic lupus erythematosus
  • rash generalised
  • inner ear inflammation
  • liver injury
  • nausea
  • pneumonia
  • pruritus
  • rash
  • renal failure acute
50-59:
  • nausea
  • pruritus
  • fatigue
  • headache
  • malaise
  • migraine
60+:
  • drug administration error
  • drug ineffective
  • myelitis transverse
  • pyrexia
  • stress fracture
  • weight decreased
  • myelodysplastic syndrome
  • thrombocytopenia
  • arthritis

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Orencia and Pamelor?

Can you answer these questions?

More questions for: Orencia, Pamelor

You may be interested in these reviews

More reviews for: Orencia, Pamelor

On eHealthMe, Orencia (abatacept) is often used to treat rheumatoid arthritis. Pamelor (nortriptyline hydrochloride) is often used to treat depression. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.